Comparison Study of SIBP's MMR Vaccine Versus GSK MMR Vaccine in Children Aged 9-11 Months

PHASE3RecruitingINTERVENTIONAL
Enrollment

1,200

Participants

Timeline

Start Date

June 28, 2024

Primary Completion Date

June 20, 2025

Study Completion Date

June 20, 2025

Conditions
Measles-Mumps-Rubella
Interventions
BIOLOGICAL

SIBP MMR Vaccine

This is a live attenuated measles, mumps, and rubella combined vaccine (Shanghai MMR) in a freeze-dried powder form, developed and manufactured by Shanghai Institute of Biological Products. A single dose of 0.5 mL, containing not less than 3.0 log CCID50 of both live measles virus and rubella virus and 4.3 log CCID50 of live mumps virus. 0.5ml per dose.

BIOLOGICAL

GSK MMR Vaccine (PRIORIX)

PRIORIX (combined measles, mumps and rubella vaccine, live, attenuated) is a lyophilized mixed preparation of the attenuated Schwarz measles, RIT 4385 mumps (derived from Jeryl Lynn strain) and Wistar RA 27/3 rubella strains of viruses, separately obtained by propagation either in chick embryo tissue cultures (mumps and measles) or MRC5 human diploid cells (rubella). 0.5ml per dose.

BIOLOGICAL

Yellow Fever Vaccine (Stamaril)

This is a live, attenuated, lyophilized yellow fever vaccine manufactured by Sanofi Pasteur Europe, Lyon, France. A single dose of 0.5 mL contains with not less than 1000 IU of yellow fever virus 17D-204 strain. 0.5ml per dose.

Trial Locations (1)

Unknown

RECRUITING

Victoria Biomedical Research Institute(VIBRI), Kisumu

All Listed Sponsors
collaborator

Victoria Biomedical Research Institute

OTHER

lead

Shanghai Institute Of Biological Products

INDUSTRY